Clinical trial

Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary…

NCT00428454 · R&D Cardiologie, Other · Completed

Key facts

NCT number NCT00428454
Title Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions
Official title A Randomized Comparison of Sirolimus-eluting Stent Implantation With Zotarolimus-eluting Stent Implantation for the Treatment of Chronic Total Coronary Occlusions. The PRISON III Trial.
Lead sponsor R&D Cardiologie, Other
Collaborators Cordis US Corp. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Disease, Coronary Disease, Coronary Stenosis
Intervention type Device
Interventions sirolimus-eluting stent, zotarolimus-eluting stent
Enrollment 301
Start date Jan 1, 2007
Primary completion Dec 1, 2010
Completion Jun 1, 2015
First posted Jan 30, 2007
Last update posted Jun 4, 2015
Countries Belgium, Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies